Manage episode 222151219 series 2394758
The stock market's November swoon could make it time to buy these top healthcare stocks. Here's how Insulet's disrupting diabetes treatment, Wellcare Health's benefiting from aging America, HCP's capitalizing on demand for life sciences real estate, and Celgene's side-stepping risk to its best selling drug. Stocks: PODD, WCG, HCP, CELG
Check out more of our content here:
Or, reach us by email @ IndustryFocus@fool.com
1323 episodes available. A new episode about every day averaging 33 mins duration .